Chong Kok Teo

Title: The Innovative Contributions of Chong Kok Teo

Introduction

Chong Kok Teo is a notable inventor based in Singapore, recognized for his significant contributions to the field of biotechnology. He holds a patent that showcases his expertise in developing innovative solutions for cancer detection and treatment. His work reflects a commitment to advancing medical science through targeted research and development.

Latest Patents

Chong Kok Teo's most recent patent is titled "Anti oligosaccharide antibody." This invention involves an antigen-binding protein that specifically binds to a Lewis X type glycan on SLAMF7. The patent details a heavy chain variable domain with specific amino acid sequences for VHCDR1, VHCDR2, and VHCDR3, as well as a light chain variable domain with corresponding sequences for VLCDR1, VLCDR2, and VLCDR3. The patent also outlines methods for using the antibody in detecting or treating cancer, along with a kit that includes the antibody. He has been granted 1 patent for this innovative work.

Career Highlights

Chong Kok Teo has had a distinguished career, working with prominent institutions such as the Agency for Science, Technology and Research and the National University of Singapore. His roles in these organizations have allowed him to contribute to significant advancements in research and development in the field of biotechnology.

Collaborations

Chong Kok Teo has collaborated with esteemed colleagues, including Andre Boon Hwa Choo and Wee Joo Chng. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Chong Kok Teo's contributions to biotechnology, particularly in cancer research, highlight his role as an influential inventor. His patent on the anti oligosaccharide antibody exemplifies his dedication to improving medical diagnostics and treatments. Through his work, he continues to make a meaningful impact in the field.